Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1996
06/20/1996WO1996018734A1 Production of recombinant secretory component
06/20/1996WO1996018733A2 Ribozyme-mediated inactivation of leukemia-associated rna
06/20/1996WO1996018732A2 Sequence-specific inhibition of dna synthesis by triplex-forming oligonucleotides
06/20/1996WO1996018730A1 Prostatic growth factor
06/20/1996WO1996018726A1 Compositions and methods for stimulating hematopoietic cell expansion
06/20/1996WO1996018725A1 Human tissue inhibitor of metalloproteinase-4
06/20/1996WO1996018654A1 Factor vii fragment 82-128 and its use in blood-clotting disorders
06/20/1996WO1996018653A1 Disulphide-cyclo-[h-cys-glu-gln-tyr-cys-oh], and its use in blood-clotting disorders
06/20/1996WO1996018652A1 Hexapeptides possessing antitumor activity
06/20/1996WO1996018651A1 Human somatostatin-like receptor
06/20/1996WO1996018650A1 Novel receptor
06/20/1996WO1996018649A1 Improved cyclic crf agonists
06/20/1996WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
06/20/1996WO1996018647A1 Spray dried erythropoietin
06/20/1996WO1996018646A2 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
06/20/1996WO1996018644A1 Aromatic heterocyclic derivatives as enzyme inhibitors
06/20/1996WO1996018643A1 Tachykinin antagonists
06/20/1996WO1996018642A1 Amino acids for making betides and methods of screening and making betide libraries
06/20/1996WO1996018641A1 Modulators of the function of fas/apo1 receptors
06/20/1996WO1996018640A1 Antisense nucleic acid homolog
06/20/1996WO1996018639A1 Novel protein tyrosine kinase, jak3
06/20/1996WO1996018627A1 Ahpba-containing tripeptide derivative
06/20/1996WO1996018419A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c
06/20/1996WO1996018418A1 Improved adenoviral vectors and producer cells
06/20/1996WO1996018417A1 Crystalline protein controlled release compositions
06/20/1996WO1996018414A1 Acellular anti-bordetella vaccine
06/20/1996WO1996018413A1 Carcinoma treatment
06/20/1996WO1996018412A1 Chimeric cytokines and uses thereof
06/20/1996WO1996018411A1 Localized delivery of factors enhancing survival of transplanted cells
06/20/1996WO1996018410A1 Agent for treating primary liver cancer and a method of treating primary liver cancer
06/20/1996WO1996018409A1 In vivo activation of tumor-specific cytotoxic t cells
06/20/1996WO1996018408A1 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
06/20/1996WO1996018402A1 Cobalt schiff base compounds
06/20/1996WO1996018313A1 Increasing creatine and glycogen concentration in muscle
06/20/1996WO1996015234A3 Lipid-splitting enzyme
06/20/1996WO1996013286A3 Modulation of cell proliferation and wound healing
06/20/1996WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
06/20/1996WO1996003993A3 Modulation of thymocyte and t cell functional activity
06/20/1996WO1996002276A3 Novel polymer gel networks and methods of use
06/20/1996DE4445317A1 Topical compsns. contg. hirudin or heparin
06/20/1996DE4444753A1 Prodn. of casein-alpha-s2 peptide(s) with antibiotic activity
06/20/1996CA2207921A1 Novel receptor
06/20/1996CA2207748A1 Cobalt schiff base compounds
06/20/1996CA2207736A1 In vivo activation of tumor-specific cytotoxic t cells
06/20/1996CA2207626A1 Novel protein tyrosine kinase, jak3
06/20/1996CA2207593A1 Method and reagent for treatment of arthritic conditions, induction of graft tolerance and reversal of immune responses
06/20/1996CA2207576A1 Improved cyclic crf agonists
06/20/1996CA2206683A1 Improved adenoviral vectors and producer cells
06/20/1996CA2206669A1 Human tissue inhibitor of metalloproteinase-4
06/20/1996CA2206400A1 Aromatic heterocyclic derivatives as enzyme inhibitors
06/20/1996CA2206258A1 Amino acids for making betides and methods of screening and making betide libraries
06/20/1996CA2205572A1 Chimeric cytokines and uses thereof
06/20/1996CA2204130A1 Tachykinin antagonists
06/20/1996CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling
06/19/1996EP0717110A1 LGMD gene
06/19/1996EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
06/19/1996EP0717048A1 Cyclic hexapeptides and their mixings, process to synthesize them and their use
06/19/1996EP0716710A1 Methods of suppressing immune response by gene therapy
06/19/1996EP0716701A1 Cloning of a member of the serine-threonine-kinase family
06/19/1996EP0716696A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
06/19/1996EP0716694A1 Human glucagon-like 1 peptide receptor
06/19/1996EP0716692A1 Methods of suppressing autoimmune response
06/19/1996EP0716691A1 Methods of suppressing graft rejection
06/19/1996EP0716662A1 Dna encoding prostaglandin receptor ep2
06/19/1996EP0716661A1 Pseudo- and non-peptide bradykinin receptor antagonists
06/19/1996EP0716660A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
06/19/1996EP0716659A1 Epiligrin, an epithelial ligand for integrins
06/19/1996EP0716658A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars
06/19/1996EP0716614A1 Treatment of human tumors by genetic transformation of human tumor cells
06/19/1996EP0716611A1 Method to reduce myocardial injury during acute myocardial infarction
06/19/1996EP0716610A1 Neural regeneration using human bone morphogenetic proteins
06/19/1996EP0716609A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-$g(b) ACTIVITY
06/19/1996EP0716604A1 Thiol-derivatized nucleosides and oligonucleosides
06/19/1996EP0716591A1 METHODS AND COMPOSITIONS FOR BINDING TAU AND MAP2c PROTEINS
06/19/1996EP0621899B1 Expression signal-peptide-free staphylokinases
06/19/1996EP0605504B1 Cosmetic and dermatological preparations
06/19/1996EP0580817B1 Pharmaceutical formulation and process
06/19/1996EP0563134B1 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
06/19/1996EP0535192B1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same
06/19/1996EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor
06/19/1996EP0516851B1 Physiologically active substance well capable of permeating biomembrane
06/19/1996EP0506923B1 A collagen binding protein as well as its preparation
06/19/1996EP0495852B1 Modified biological material
06/19/1996EP0489089B1 Therapeutic peptides
06/19/1996EP0418310B1 Gene for encoding a human malaria vaccine antigen
06/19/1996CN1124964A Trifunctional antithrombin and antiplatelet peptides
06/19/1996CN1124929A Novel agent for controlling cell activity
06/19/1996CN1124927A Analogs of peptide YY and uses thereof
06/19/1996CN1124779A Method of diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by analysis of IRF-1-spectific RNA in biopsy samples
06/19/1996CN1124739A Vaccin peptide of blood fluke
06/19/1996CN1124656A Medicinal biological response regulating agent of cooperative polysaccharide modification
06/19/1996CN1124617A Lyophilized bougie and producing process thereof
06/18/1996USRE35277 Cell membrane proteins, compositions containing them and procedure for their preparation
06/18/1996US5527897 Genetic engineering
06/18/1996US5527884 Mediators of chronic allograft rejection and DNA molecules encoding them
06/18/1996US5527881 Procedure for preparing salmon calcitonin
06/18/1996US5527856 Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
06/18/1996US5527807 Treating alopecia, acne, prostate disorders
06/18/1996US5527795 Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/18/1996US5527778 Method for selective opening of abnormal brain tissue capillaries